Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02186470 · ClinicalTrials.gov registry record · NA
Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT02186470 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 22 participants.
The verdict
NCT02186470, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
This pilot clinical trial studies intensity-modulated accelerated partial breast irradiation (APBI) before surgery in treating older patients with estrogen receptor positive or progesterone receptor positive stage I breast cancer. APBI is a specialized type of radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Giving radiation therapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed.
Interventions
- PROCEDURE therapeutic conventional surgery
- RADIATION intensity-modulated radiation therapy
- RADIATION image-guided radiation therapy
- RADIATION accelerated partial breast irradiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2016-04-29 |
| Est. Completion | 2025-09-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02186470
The ClinicalTrials.gov registry entry for NCT02186470 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which therapeutic conventional surgery is the first listed.
NCT02186470 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02186470 about?
NCT02186470 is a clinical study titled "Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer". This pilot clinical trial studies intensity-modulated accelerated partial breast irradiation (APBI) before surgery in treating older patients with estrogen receptor positive or progesterone receptor positive stage I breast cancer. APBI is a specialized type of radiation therapy that delivers a high ...
What is the current status of trial NCT02186470?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2016-04-29. Estimated completion is 2025-09-04.
What interventions are being tested in trial NCT02186470?
The interventions under investigation include: therapeutic conventional surgery (PROCEDURE), intensity-modulated radiation therapy (RADIATION), image-guided radiation therapy (RADIATION), accelerated partial breast irradiation (RADIATION).
Who is sponsoring clinical trial NCT02186470?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.